Literature DB >> 16300860

Synthesis and antiamoebic activity of new 1-N-substituted thiocarbamoyl-3,5-diphenyl-2-pyrazoline derivatives and their Pd(II) complexes.

Asha Budakoti1, Mohammad Abid, Amir Azam.   

Abstract

Some 1-N-substituted thiocarbamoyl-3,5-diphenyl-2-pyrazoline derivatives (L), 1-8 were synthesized by a base-catalyzed Claisen-Schmidt condensation of benzaldehyde with acetophenone followed by cyclization with various N-4 substituted thiosemicarbazides. The palladium(II) complexes [PdLCl2], 1a-8a of these ligands were obtained by reacting them with [Pd(DMSO)2Cl2]. All compounds have been characterized by means of elemental analyses, electronic, IR, 1H NMR and mass spectroscopic data, while the complexes have additionally been characterized by thermogravimetric patterns. The in vitro antiamoebic activity was evaluated against the HM1:IMSS strain of Entamoeba histolytica and the results were compared with the standard drug, metronidazole. The preliminary test results showed that the complexes had better antiamoebic activity than their respective ligands. Moreover, the complexes showed better inhibition of the test organism. The results suggest that the ligands 4, 7 and the complexes 2a-4a, 6a-8a were found with IC50 lower than that of the standard drug metronidazole and thus are better inhibitor of growth of E. histolytica.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16300860     DOI: 10.1016/j.ejmech.2005.06.013

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  4 in total

Review 1.  Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites.

Authors:  Vahab Ali; Tomoyoshi Nozaki
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

2.  Crystal structure of ethyl 2-[2-((1E)-{(1E)-2-[2-(2-eth-oxy-2-oxoeth-oxy)benzyl-idene]hydrazin-1-yl-idene}meth-yl)phen-oxy]acetate.

Authors:  Joel T Mague; Shaaban K Mohamed; Mehmet Akkurt; Eman A Ahmed; Omran A Omran
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-01-01

Review 3.  Recent advances in the therapeutic applications of pyrazolines.

Authors:  Mohamed R Shaaban; Abdelrahman S Mayhoub; Ahmad M Farag
Journal:  Expert Opin Ther Pat       Date:  2012-03-08       Impact factor: 6.674

4.  Utility of 5-(furan-2-yl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazole-1-carbothioamide in the synthesis of heterocyclic compounds with antimicrobial activity.

Authors:  Abdou O Abdelhamid; Ibrahim E El Sayed; Yasser H Zaki; Ahmed M Hussein; Mangoud M Mangoud; Mona A Hosny
Journal:  BMC Chem       Date:  2019-04-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.